AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.63−0.57 (-3.52%)
Close on Nov 13, 2026Market cap $483.39MP/E –Yield –
AVITA Medical total assets
Total assets on the balance sheet at the end of each period.
AVITA Medical's total assets was $46.79M at Sep 30, 2026. For fiscal 2025 it was $56.39M, down 29.3% from the year before. The highest annual figure on record is $125.50M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.39M | -29.3% |
| FY2024 | Dec 31, 2024 | $79.71M | -28.6% |
| FY2023 | Dec 31, 2023 | $111.64M | -11.0% |
| FY2021 | Jun 30, 2021 | $125.50M | +52.2% |
| FY2020 | Jun 30, 2020 | $82.46M | +219.8% |
| FY2019 | Jun 30, 2019 | $25.78M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $46.79M | -26.6% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $47.78M | -17.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $51.54M | -25.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $56.39M | -29.3% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $63.73M | -21.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $58.13M | -33.8% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $69.56M | -28.6% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $79.71M | -28.6% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $81.05M | +0.0% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $87.83M | +1.7% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $97.38M | +5.1% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $111.64M | -11.0% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $81.01M | -36.8% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $86.33M | +24.6% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $92.62M | +22.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $125.50M | +52.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $128.09M | +396.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $69.31M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $75.42M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $82.46M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $25.78M | – |
See a number that looks wrong?